| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Intellia Therapeutics, Inc.'s insiders have reduced their positions by a net 8,111 shares worth roughly $91K. In the past 30 days, 0 insiders bought and 1 sold. The bias lately has been to the sell side.
Not all activity pointed one way: 1 insider sold in the same window, though they still hold shares. Classified under Biotechnology (Health Care sector), NTLA's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.01M | $12.18M | - | |
| Dir | 207.5K | $2.49M | - | |
| CFO | 148.2K | $1.78M | -8,111 | |
| Dir | 134.7K | $1.62M | - | |
| VP | 121.2K | $1.46M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 17, 2024 | Verwiel Frank | Director | Sell | 1,505 | $25.00 | $37,625.00 | -7.7% | -14.5% | -61.9% | |
| Mar 4, 2024 | Basta James72 | EVP, General Counsel | Sell | 2,297 | $32.99 | $75,778.03 | -2.7% | -27.4% | -71.9% | |
| Mar 4, 2024 | Clark Eliana75 | EVP, Chief Technical Officer | Sell | 605 | $32.99 | $19,958.95 | -0.8% | -27.4% | -71.9% | |
| Jan 8, 2024 | Sepp-Lorenzino Laura83 | EVP, Chief Scientific Officer | Sell | 2,275 | $28.87 | $65,681.74 | -2.5% | -15.9% | -58.5% | |
| Jan 3, 2024 | Leonard John M83 | President And CEO | Sell | 19,223 | $29.46 | $566,309.58 | -2.2% | -14.9% | -58.6% | |
| Jan 3, 2024 | Lebwohl David87 | EVP, Chief Medical Officer | Sell | 5,843 | $29.46 | $172,134.78 | -9.7% | -14.9% | -58.6% | |
| Jan 3, 2024 | Sepp-Lorenzino Laura83 | EVP, Chief Scientific Officer | Sell | 5,532 | $29.46 | $162,972.72 | -10.7% | -14.9% | -58.6% | |
| Jan 3, 2024 | Goddard Glenn83 | EVP, Chief Financial Officer | Sell | 5,365 | $29.46 | $158,052.90 | -11.7% | -14.9% | -58.6% | |
| Jan 3, 2024 | Hicks Derek71 | EVP, Chief Business Officer | Sell | 3,877 | $29.46 | $114,216.42 | -9.5% | -14.9% | -58.6% | |
| Jan 3, 2024 | Basta James72 | EVP, General Counsel | Sell | 3,805 | $29.46 | $112,095.30 | -6.9% | -14.9% | -58.6% |